Abstract
An inflammatory abdominal aortic aneurysm complicated by primary aortoduodenal fistula was successfully treated by stent grafting. Pharmacotherapy with octreotide after endovascular aneurysm repair was also performed with the expectation of spontaneous and rapid closure of the fistula. Gastrointestinal endoscopy performed 10 days after endovascular aneurysm repair showed closure of the large aortoduodenal fistula, and oral intake was started on the operative day 16. To date, 16 months after the initial operation, the patient is doing well without any symptoms or signs of infection and without any antibiotic therapy.
Copyright © 2011 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Aged
-
Anti-Bacterial Agents / therapeutic use*
-
Aortic Aneurysm, Abdominal / complications
-
Aortic Aneurysm, Abdominal / diagnosis
-
Aortic Aneurysm, Abdominal / therapy*
-
Aortic Diseases / diagnosis
-
Aortic Diseases / etiology
-
Aortic Diseases / therapy*
-
Aortography / methods
-
Blood Vessel Prosthesis
-
Blood Vessel Prosthesis Implantation* / instrumentation
-
Cefoperazone / therapeutic use
-
Drug Combinations
-
Duodenal Diseases / diagnosis
-
Duodenal Diseases / etiology
-
Duodenal Diseases / therapy*
-
Endoscopy, Gastrointestinal
-
Endovascular Procedures* / instrumentation
-
Gastrointestinal Agents / therapeutic use*
-
Humans
-
Intestinal Fistula / diagnosis
-
Intestinal Fistula / etiology
-
Intestinal Fistula / therapy*
-
Male
-
Octreotide / therapeutic use
-
Stents
-
Sulbactam / therapeutic use
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Vascular Fistula / diagnosis
-
Vascular Fistula / etiology
-
Vascular Fistula / therapy*
Substances
-
Anti-Bacterial Agents
-
Drug Combinations
-
Gastrointestinal Agents
-
Cefoperazone
-
Octreotide
-
Sulbactam